These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38718757)

  • 1. Hepatic selective insulin resistance at the intersection of insulin signaling and metabolic dysfunction-associated steatotic liver disease.
    Bo T; Gao L; Yao Z; Shao S; Wang X; Proud CG; Zhao J
    Cell Metab; 2024 May; 36(5):947-968. PubMed ID: 38718757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of selective insulin resistance in isolated hepatocytes.
    Cook JR; Langlet F; Kido Y; Accili D
    J Biol Chem; 2015 May; 290(22):13972-80. PubMed ID: 25873396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resolving the Paradox of Hepatic Insulin Resistance.
    Santoleri D; Titchenell PM
    Cell Mol Gastroenterol Hepatol; 2019; 7(2):447-456. PubMed ID: 30739869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differing endoplasmic reticulum stress response to excess lipogenesis versus lipid oversupply in relation to hepatic steatosis and insulin resistance.
    Ren LP; Chan SM; Zeng XY; Laybutt DR; Iseli TJ; Sun RQ; Kraegen EW; Cooney GJ; Turner N; Ye JM
    PLoS One; 2012; 7(2):e30816. PubMed ID: 22355328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct and systemic actions of growth hormone receptor (GHR)-signaling on hepatic glycolysis, de novo lipogenesis and insulin sensitivity, associated with steatosis.
    Vázquez-Borrego MC; Del Río-Moreno M; Pyatkov M; Sarmento-Cabral A; Mahmood M; Pelke N; Wnek M; Cordoba-Chacon J; Waxman DJ; Puchowicz MA; McGuinness OP; Kineman RD
    Metabolism; 2023 Jul; 144():155589. PubMed ID: 37182789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathway-selective insulin resistance and metabolic disease: the importance of nutrient flux.
    Otero YF; Stafford JM; McGuinness OP
    J Biol Chem; 2014 Jul; 289(30):20462-9. PubMed ID: 24907277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Swertiamarin ameliorates oleic acid induced lipid accumulation and oxidative stress by attenuating gluconeogenesis and lipogenesis in hepatic steatosis.
    Patel TP; Rawal K; Soni S; Gupta S
    Biomed Pharmacother; 2016 Oct; 83():785-791. PubMed ID: 27490779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones.
    Geisler CE; Renquist BJ
    J Endocrinol; 2017 Jul; 234(1):R1-R21. PubMed ID: 28428362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein A4 Restricts Diet-Induced Hepatic Steatosis via SREBF1-Mediated Lipogenesis and Enhances IRS-PI3K-Akt Signaling.
    Cheng C; Liu XH; He J; Gao J; Zhou JT; Fan JN; Jin X; Zhang J; Chang L; Xiong Z; Yu J; Li S; Li X
    Mol Nutr Food Res; 2022 Sep; 66(18):e2101034. PubMed ID: 35909347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The adipokine sFRP4 induces insulin resistance and lipogenesis in the liver.
    Hörbelt T; Knebel B; Fahlbusch P; Barbosa D; de Wiza DH; Van de Velde F; Van Nieuwenhove Y; Lapauw B; Thoresen GH; Al-Hasani H; Müller-Wieland D; Ouwens DM; Kotzka J
    Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2671-2684. PubMed ID: 31336149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic fatty acid and glucose handling in metabolic disease: Potential impact on cardiovascular disease risk.
    Westcott F; Dearlove DJ; Hodson L
    Atherosclerosis; 2024 Jul; 394():117237. PubMed ID: 37633797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human skin stem cell-derived hepatic cells as in vitro drug discovery model for insulin-driven de novo lipogenesis.
    Buyl K; Vrints M; Fernando R; Desmae T; Van Eeckhoutte T; Jans M; Van Der Schueren J; Boeckmans J; Rodrigues RM; De Boe V; Rogiers V; De Kock J; Beirinckx F; Vanhaecke T
    Eur J Pharmacol; 2023 Oct; 957():175989. PubMed ID: 37572939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased insulin receptor substrate 2 expression is associated with steatohepatitis and altered lipid metabolism in obese subjects.
    Rametta R; Mozzi E; Dongiovanni P; Motta BM; Milano M; Roviaro G; Fargion S; Valenti L
    Int J Obes (Lond); 2013 Jul; 37(7):986-92. PubMed ID: 23147115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fructose as a key player in the development of fatty liver disease.
    Basaranoglu M; Basaranoglu G; Sabuncu T; Sentürk H
    World J Gastroenterol; 2013 Feb; 19(8):1166-72. PubMed ID: 23482247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing liver mitochondrial fatty acid oxidation capacity in obese mice improves insulin sensitivity independently of hepatic steatosis.
    Monsénégo J; Mansouri A; Akkaoui M; Lenoir V; Esnous C; Fauveau V; Tavernier V; Girard J; Prip-Buus C
    J Hepatol; 2012 Mar; 56(3):632-9. PubMed ID: 22037024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MLX plays a key role in lipid and glucose metabolism in humans: Evidence from in vitro and in vivo studies.
    Nagarajan SR; Livingstone EJ; Monfeuga T; Lewis LC; Ali SHL; Chandran A; Dearlove DJ; Neville MJ; Chen L; Maroteau C; Ruby MA; Hodson L
    Metabolism; 2023 Jul; 144():155563. PubMed ID: 37088121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic CREBZF couples insulin to lipogenesis by inhibiting insig activity and contributes to hepatic steatosis in diet-induced insulin-resistant mice.
    Zhang F; Hu Z; Li G; Huo S; Ma F; Cui A; Xue Y; Han Y; Gong Q; Gao J; Bian H; Meng Z; Wu H; Long G; Tan Y; Zhang Y; Lin X; Gao X; Xu A; Li Y
    Hepatology; 2018 Oct; 68(4):1361-1375. PubMed ID: 29637572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unraveling the Regulation of Hepatic Metabolism by Insulin.
    Titchenell PM; Lazar MA; Birnbaum MJ
    Trends Endocrinol Metab; 2017 Jul; 28(7):497-505. PubMed ID: 28416361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of SCAP/SREBP as Central Regulators of Lipid Metabolism in Hepatic Steatosis.
    Chandrasekaran P; Weiskirchen R
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Branched-chain amino acids alter cellular redox to induce lipid oxidation and reduce de novo lipogenesis in the liver.
    Surugihalli C; Muralidaran V; Ryan CE; Patel K; Zhao D; Sunny NE
    Am J Physiol Endocrinol Metab; 2023 Apr; 324(4):E299-E313. PubMed ID: 36791321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.